In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients

PURPOSE: To generate a preclinical model of isocitrate dehydrogenase (IDH) mutant gliomas from glioma patients and design a MRS method to test the compatibility of 2-hydroxyglutarate (2HG) production between the preclinical model and patients. METHODS: Five patient-derived xenograft (PDX) mice were...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Magn Reson Med
Autores principales: Tiwari, Vivek, Mashimo, Tomoyuki, An, Zhongxu, Vemireddy, Vamsidhara, Piccirillo, Sara, Askari, Pegah, Hulsey, Keith M., Zhang, Shanrong, de Graaf, Robin A., Patel, Toral R., Pan, Edward, Mickey, Bruce E., Maher, Elizabeth A., Bachoo, Robert M., Choi, Changho
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7263951/
https://ncbi.nlm.nih.gov/pubmed/32003035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mrm.28183
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares